Security Snapshot

Yarrow Bioscience, Inc. - Common Stock, par value $0.0001 per share (YARW) Institutional Ownership

CUSIP: 92941V407

13F Institutional Holders and Ownership History for Q3 2026

13F reference period

Q3 2026

Institutions Reporting

36

Shares (Excl. Options)

7.95MFull value: 7,952,810 · shares · 30 Sep 2026

Price

$22.52

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+6,926,552
Value change
+$155,972,933
Number of holders
36
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
15,360,259
SEC-reported price per share
$20.12
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • YARW - Yarrow Bioscience, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 92941V407.
  • 36 institutions reported positions in Q3 2026.
  • 14 significant owners is listed from Schedule 13D/13G reporting.

Change

  • The headline uses Q3 2026 reported holdings.
  • Quarter-over-quarter comparison is unavailable because the immediately preceding quarter is missing.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 36 institutions filings for Q3 2026.

Open SEC evidence

Security key

92941V407

13F reference period

Q3 2026

13F holders

36

13D/G owners

14

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
14
Security
YARW
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 10% 0% $32,205,018 +$26,837,887 1,600,647 +500% Perceptive Advisors LLC 30 Sep 2026
venBio Global Strategic Fund V, L.P. 10% 0% $24,381,818 +$18,761,498 1,211,820 +334% venBio Global Strategic Fund V, L.P. 30 Sep 2026
RTW Fund Group GP, LLC 9.9% -0.9% $21,299,771 +$16,346,461 1,145,149 +330% RTW Fund Group GP, LLC 30 Sep 2026
Logos Global Management LP 10% -6.5% $20,271,121 +$14,510,604 1,007,511 +252% Logos Global Management LP 30 Sep 2026
Bellevue Group AG 11% $27,010,000 1,000,000 Bellevue Group AG 10 Sep 2026
AMERIPRISE FINANCIAL INC 8.6% $13,755,407 739,538 Ameriprise Financial, Inc. 30 Sep 2026
Invus Global Management, LLC 7.2% $26,237,250 675,000 Raymond Debbane 11 Sep 2026
Spruce Street Capital LP 6.4% $11,297,305 607,382 Spruce Street Capital LP 30 Sep 2026
Janus Henderson Group Ltd. 3% -70% $5,270,143 +$309,299 283,341 +6.2% JANUS HENDERSON GROUP Ltd. 30 Sep 2026
ADAR1 Capital Management, LLC 2.5% -70% $5,693,880 +$4,506,800 282,996 +380% ADAR1 Capital Management, LLC 30 Sep 2026
ORBIMED ADVISORS LLC 10% 266,306 ORBIMED ADVISORS LLC 27 Jul 2026
AI Biotechnology LLC 1.2% -81% $3,584,961 -$20.12 178,179 -0% AI Biotechnology LLC 13 Nov 2026
Zhang Xiaofan 0.6% 162,452 Zhang Xiaofan 13 Aug 2026
Nantahala Capital Management, LLC 0.46% $729,083 39,198 Nantahala Capital Management, LLC 30 Sep 2026
As of 30 Sep 2026, 36 institutional investors reported holding
7.95MFull value: 7,952,810 · shares · 30 Sep 2026
shares of Yarrow Bioscience, Inc. - Common Stock, par value $0.0001 per share (YARW). This represents 52% of the company’s total
15.36MFull value: 15,360,259 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
51%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Logos Global Management LP 6.7% 1,026,258 1.3% $23,111,330
Bellevue Group AG 6.5% 1,000,000 0.47% $22,520,000
PERCEPTIVE ADVISORS LLC 5.3% 813,098 0.34% $18,310,966
Siren, L.L.C. 4.4% 675,000 0.36% $15,201,000
Spruce Street Capital LP 4% 607,382 2.2% $13,678,243
venBio Partners LLC 3.6% 554,769 2.5% $12,493,398
Soleus Capital Management, L.P. 2.7% 416,993 0.33% $9,390,682
VANGUARD CAPITAL MANAGEMENT LLC 2.4% 368,034 0% $8,288,126
BRAIDWELL LP 2.2% 331,400 0.31% $7,463,128
Driehaus Capital Management LLC 2% 305,000 0.05% $6,868,600
SILVERARC CAPITAL MANAGEMENT, LLC 2% 301,919 0.83% $6,799,216
Janus Henderson Group Ltd. 1.8% 283,341 0% $6,366,672
ORBIMED ADVISORS LLC 1.7% 266,306 0.11% $5,997,211
MARSHALL WACE, LLP 1.5% 237,183 0.01% $5,341,361
Squadron Capital Management LLC 1.5% 225,000 1.5% $5,067,000
GEODE CAPITAL MANAGEMENT, LLC 0.55% 84,720 0% $1,909,046
J. Goldman & Co LP 0.36% 55,751 0.04% $1,255,513
VANGUARD FIDUCIARY TRUST CO 0.33% 50,629 0% $1,140,165
Monashee Investment Management LLC 0.26% 40,000 2.7% $900,800
Seven Fleet Capital Management LP 0.26% 40,000 0.18% $900,800
Nantahala Capital Management, LLC 0.26% 39,198 0.05% $882,739
Qube Research & Technologies Ltd 0.16% 23,954 0% $539,444
TWO SIGMA INVESTMENTS, LP 0.16% 23,811 0% $536,224
Lynx1 Capital Management LP 0.14% 22,000 0.08% $495,440
PRELUDE CAPITAL MANAGEMENT, LLC 0.11% 16,975 0.03% $382,277

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
1
Headline period
Q3 2026
Rows shown
1-1 of 1
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 7,952,810 $179,084,263 +$155,972,933 $22.52 36
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .